Chronic Myelogenous Leukemia Therapeutics Market by Product and Geography - Global Forecast and Analysis 2019-2023

Published: Aug 2019

Pages: 157

SKU: IRTNTR31940

Snapshot

The chronic myelogenous leukemia therapeutics market size will grow by USD 1.74 billion during 2019-2023. This market report provides a detailed analysis of the market by product (targeted therapy, chemotherapy, and immunotherapy) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on many market vendors, including Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Mylan NV, Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.

Key Insights on Chronic Myelogenous Leukemia Therapeutics Market – Global Forecast 2019-2023

Browse TOC and LoE with selected illustrations and example pages of Chronic Myelogenous Leukemia Therapeutics Market

Request a FREE sample now!

Industry Overview

The CML therapeutics market has witnessed a number of strategic alliances over recent years. Market vendors are focusing on collaborations to expand their distribution networks and reduce costs associated with the R&D of CML therapeutics. Collaborations among vendors are influencing market growth by increasing patient adherence by reducing the cost burden. For instance, the BMS recently collaborated with The MAX Foundation to provide free drugs to patients who are unable to access the treatment. The strategic alliances between vendors have also increased the development of diagnostic kits and testing services, which have resulted in the early diagnosis of the disease and increased adoption for the treatment. Effective alliances among companies will significantly fuel the growth of the CML therapeutics market size during 2019-2023.

Crucial chronic myelogenous leukemia therapeutics market trends such as the development of diagnostic tests and predictive markers will also influence market growth. The high unmet need is encouraging companies to research diagnostic testing methods that help in the early detection of CML. These developments include diagnostic kits in oncology to effectively monitor the molecular response of the indication at an early stage. Vendors are also introducing predictive biomarkers for CML for the intrinsic sensitivity of TKI drugs. For instance, HMGCLL1 is a predictive biomarker in CML for deep molecular response to imatinib therapy.

Similarly, microRNAs are used as biomarkers to study the progression of CML and the resistance to TKI drugs. These developments are expected to enhance the effectiveness of CML therapy drugs. As a result of these factors, the myelogenous leukemia therapeutics market will register a CAGR of nearly 6% during the forecast period.

Top Companies in Chronic Myelogenous Leukemia Therapeutics Market

The global market is fragmented. To help clients improve their market positions, this chronic myelogenous leukemia therapeutics market forecast report provides an analysis of the market’s competitive landscape and offers information on the products offered by various companies. This chronic myelogenous leukemia therapeutics market analysis report also includes information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

The report offers a detailed analysis of several leading chronic myelogenous leukemia therapeutics companies, including:

Market Segmentation

Chronic Myelogenous Leukemia Market by Product

Targeted therapy
Chemotherapy
Immunotherapy

The targeted therapy segment held the largest market share in 2018. It will account for the highest chronic myelogenous leukemia therapeutics market share over the forecast period as well. The market is witnessing an increase in the number of approved TKI drugs for the treatment of chronic phase CML. The increasing number of approvals for orphan drug destinations is also fueling the growth of the segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the chronic myelogenous leukemia therapeutics market size.

Chronic Myelogenous Leukemia Therapeutics Market by Geography

Asia
Europe
North America
ROW

With a complete study of the growth opportunities for companies, it has been identified that North America will account for the highest share of the chronic myelogenous leukemia therapeutics market throughout the forecast period. Vendors operating in the region are providing patient-assistance programs, such as co-pay assistance and free trial programs to reduce patients’ burden. These patient-assistance programs are also inclusive of reimbursement support, financial co-payment assistance, medication adherence, and supportive care. Such initiatives by vendors are fueling the chronic myelogenous leukemia therapeutics market growth in North America.

Major Highlights of the Chronic Myelogenous Leukemia Therapeutics Market - Global Forecast 2019-2023

CAGR of the market during the forecast period 2019-2023
Detailed information on factors that will accelerate the growth of the chronic myelogenous leukemia therapeutics market size during the next five years
Precise estimation of the global chronic myelogenous leukemia therapeutics market size and its contribution to the parent market
Accurate chronic myelogenous leukemia therapeutics market forecast on upcoming trends and changes in consumer behavior
The growth of the chronic myelogenous leukemia therapeutics industry across Asia, Europe, North America, and ROW
A thorough analysis of the market’s competitive landscape and detailed information on several vendors
Comprehensive details of factors that will challenge the growth of chronic myelogenous leukemia therapeutics companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem
Market characteristics
Market segmentation analysis

PART 04: MARKET SIZING

Market definition
Market sizing 2018
Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product
Comparison by product
Targeted therapy - Market size and forecast 2018-2023
Chemotherapy - Market size and forecast 2018-2023
Immunotherapy - Market size and forecast 2018-2023
Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity

PART 09: DRIVERS AND CHALLENGES

Market drivers
Market challenges

PART 10: MARKET TRENDS

Emergence of pipeline molecules
Development of diagnostic tests and predictive markers
Increasing research in regenerative medicines

PART 11: VENDOR LANDSCAPE

Overview
Landscape disruption

PART 12: VENDOR ANALYSIS

PART 13: APPENDIX

Research methodology
List of abbreviations
Definition of market positioning of vendors

PART 14: EXPLORE TECHNAVIO

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis